Orders Snap Back to +16%, the Guide Rises on Growth, Margin and EPS, and $7.3B of Quantinuum Sits Outside the Multiple: Upgrading to Outperform

Results vs. Consensus

Q2 2026 Scorecard (Honeywell Technologies basis)

This is the perimeter the Street models and the perimeter management guides. It excludes Aerospace.

The Two Perimeters, Side by Side

The consolidated column still carries a full quarter of Aerospace. It is the legally reported result and it is the one that produced the $17.83 GAAP headline, but it describes a company that no longer exists. The right-hand column is the company an investor now owns.

Where the 100bp Came From

The segment-margin bridge is worth unpacking because the sources are unusually durable. Building Automation and Industrial Automation each added 90bp on volume leverage, price and productivity, while Process Automation & Technology gave back 180bp on unfavorable catalyst mix. That combination should have produced roughly flat consolidated margin. It produced 100bp of expansion because the unallocated corporate layer shrank. Honeywell Technologies' three segments generated $1,171M of profit against a reported segment profit of $985M, implying about $186M of corporate and unallocated cost; a year ago the same arithmetic gives $1,121M against $904M, or about $217M. That roughly $31M reduction, close to 14% of the drag, is the stranded-cost program showing up in the accounts rather than in a slide. It is also why margin could expand while the largest-margin segment contracted.

Segment Performance

Prior-year comparatives are the segment figures that foot to the reported totals of $9,320M of segment sales and $2,128M of segment profit (Building Automation $1,826M sales / $479M profit; Process Automation & Technology $1,613M / $386M; Industrial Automation $1,574M / $256M; Aerospace $4,307M / $1,098M; corporate and other −$91M). Industrial Automation's reported decline of 5% against organic growth of 4% is the divestiture effect: the held-for-sale businesses cost 9 points of reported growth.

Building Automation — Seven Straight High-Single-Digit Quarters, and the Verticals Are Compounding

Building Automation grew 9% organically with double-digit growth in products and continued strength in solutions, double-digit growth in both fire and services, and strength across every region led by Asia Pacific, the Middle East and the Americas. Margin expanded 90bp to 27.1% on volume leverage and price. The more interesting number is inside the mix: orders in the segment's designated high-growth verticals grew more than 50% and organic sales in those verticals grew 30%, while the core fire business still put up roughly 30% orders growth. Total segment orders rose 13%. Management sized the data-center exposure at about 5% of Building Automation, up from close to nothing three or four years ago, and described three distinct legs: the international build-out beyond the United States, on-site power generation that pulls in the process-automation business, and liquid cooling that pulls in industrial sensing.

"we will continue to expand our play in data center from almost nothing 3, 4 years back to… 5% of the building automation business. And I expect that we will be at a higher number across Honeywell as the time progresses." — Vimal Kapur, Chairman & CEO

Assessment: This is the anchor asset of the new company and the quality is not in question. Seven consecutive high-single-digit quarters with orders running ahead of sales and a vertical mix shifting toward data centers, healthcare and hospitality is a genuine compounder profile, and management conceded on the call that there is "no real logic" to why the growth rate should decay into 2027. The mild caution is that the guide only asks for mid-single-digit-plus growth from this segment, which reads as deliberate conservatism in a first standalone year rather than a view. We would treat mid-single-digits as the floor.

Process Automation & Technology — Revenue Still Negative, Orders Up 24%, and That Gap Is the Whole Story

PA&T declined 1% organically, which was nonetheless materially better than management's own plan for the quarter. The internals split cleanly: projects grew 5% on gas, LNG and petrochemicals, while aftermarket fell 6% against a tough prior-year comparison created by a large catalyst shipment in Q2 2025. That catalyst mix is also the entire explanation for the 180bp margin contraction to 22.1%, and even that came in ahead of the segment's original margin plan. The forward book is a different picture entirely: orders grew 24% organically with book-to-bill above 1.2, Middle East orders grew more than 50% on large Process Technology awards, and management says the LNG proprietary-equipment business is sold out for three years. The Johnson Matthey Catalyst Technologies acquisition closed on July 17 and folds into this segment.

"Process Automation Technologies sales declined just 1% organically in the second quarter, ahead of our prior expectations as the up cycle in energy end markets and activity in global projects begin to materialize. Projects grew 5%, driven by strength in gas, LNG and petrochemicals. This strength was offset by a 6% decline in aftermarket due primarily to a tough prior year comparison from a large catalyst shipment in the second quarter of 2025." — Mike Stepniak, SVP & CFO

Assessment: Last quarter we wrote that the PA&T second-half ramp was the single biggest swing factor in whether the full-year guide would hold, and that the backlog made it probable rather than certain. A quarter later, book-to-bill above 1.2 and 24% order growth move it meaningfully toward certain. The honest caveat is that orders are a promise and revenue is a fact, and the fact is still negative. The guide asks this segment to go from minus 1% to high-single-digit growth in two quarters. Catalyst volumes are the swing: management expects second-half catalyst shipments roughly 25–30% above the first half, and because the higher-margin proprietary catalysts are lumpy by nature, the margin recovery will be as uneven as the revenue recovery is sharp. This remains the segment we would watch hardest in Q3.

Industrial Automation — The Turnaround Has Measurable KPIs Now

Industrial Automation grew 4% organically against a reported 5% decline, the gap being the divestitures. Solutions led, helped in part by Intelligrated, which departs with the Warehouse and Workflow sale; the core business excluding planned divestitures grew 2% organically. Margin expanded 90bp to 17.2% as pricing and productivity more than offset inflation and unfavorable mix. Orders grew 10%, or 11% for the retained core, with Sensing and Industrial Measurement orders up more than 20% and strength across Europe, the Middle East and China. Management put concrete operational metrics behind the turnaround for the first time: on-time delivery performance started the year in the mid-40s and is trending toward 80%, with a high-80s target, and the CFO committed to a 22% margin rate in the fourth quarter.

Assessment: This is the segment with the widest gap between current performance and stated ambition, and therefore the most upside if the execution holds. A business improving delivery performance from the mid-40s toward the high 80s is fixing the thing that costs it share, and 20%-plus order growth in Sensing and Industrial Measurement suggests the fix is being rewarded. But the honest read on the underlying is more modest than the headline: strip the divesting businesses and the core grew 2%, and management guided the post-divestiture run-rate to roughly 2% exiting the year. The margin story is stronger than the growth story here, and a 22% fourth-quarter margin against 17.2% today is the most specific and most falsifiable commitment made on this call.

Aerospace Technologies — The Exit Quarter, and the Q1 Problem Did Resolve

Aerospace is no longer part of this company, but its final quarter inside the consolidation settles a question our Q1 recap left open. Sales grew 5% organically against the 3% that acute mechanical supply-chain constraints produced in Q1, confirming management's characterization of that shortfall as supplier-driven and transitory rather than a demand crack. Margin, however, went the other way, easing to 24.8% from 25.5% a year ago, which is a reversal of the favorable electrical-over-mechanical mix that flattered the 26.5% Q1 print exactly as management said it would.

Assessment: The supply-chain bear point that helped drive our April downgrade resolved on management's stated timeline. That is a point in favor of taking this team's characterizations at face value going forward, and it is directly relevant to how much credit to extend the Middle East and PA&T assumptions embedded in the current guide. The Aerospace margin softness is now HONA's issue rather than HON's, and HONA reports standalone on August 5.

Key Topics & Management Commentary

Overall Management Tone: The most forward-leaning posture of our five quarters of coverage, and notably it was the CFO rather than the CEO who carried it. Management raised guidance six weeks after setting it, volunteered that there is further room to exceed the raised numbers, and stated that 2027 is tracking better than the framework presented at the June Investor Day, none of which is the language of a team managing expectations down in a first standalone quarter. Where the posture was conservative it was conservative in a specific and credible direction: the Middle East guide assumes no improvement from current conditions rather than the recovery the prior quarter's guide had assumed. Analyst pushback was almost entirely absent, which is itself a signal worth noting.

1. The Order Reacceleration: 7% to 16%

Organic orders grew 16% to roughly $5.7B with book-to-bill at 1.1 and ending backlog up 9%. Every segment contributed: PA&T at 24%, Building Automation at 13%, Industrial Automation at 10%. The detail that matters most is that short-cycle orders grew double digits in every segment, because short-cycle is the part of the book that converts inside two quarters and therefore validates the second-half guide directly rather than the 2027 story.

"Orders grew 16% organically with broad-based demand across all segments, resulting in 9% increase in ending backlog. Notably, short-cycle orders grew double digit across all segments." — Vimal Kapur, Chairman & CEO

Assessment: This is the most consequential number in the print and it is the direct refutation of the specific concern that drove our downgrade. In April we wrote that orders decelerating to 7% from 22–23% "got less attention than it deserved" and that management "leaned on the record backlog rather than dwelling on the slowdown in incoming demand." Two quarters at 7% would have been a trend. One quarter at 7% followed by one at 16%, with the composition skewed to short-cycle, is a comparison artifact plus two temporary disruptions clearing. We were right to flag it and wrong about what it meant.

2. Stranded-Cost Removal Is Running Ahead of the Plan It Was Set Against

The structural half of the margin story is the removal of costs that were carried for a company twice this size. Management told the Investor Day audience in June to expect roughly $85M of stranded cost still in the run-rate at year-end; six weeks later that figure is about $20M better, implying entry into 2027 with $60–65M remaining to eliminate. Combined with Industrial Automation portfolio actions and the Aerospace trademark agreement, this is the source of more than 200bp of the three-year margin expansion target, on top of roughly 60bp per year of operational expansion.

"On margin, we have over 200 basis points of margin expansion coming quickly from stranded cost removal, portfolio actions in Industrial Automation and benefit of aerospace trademark agreement. On top of that, we expect to drive 60 basis points a year of operational margin expansion through price, improving mix, new product introduction and productivity." — Vimal Kapur, Chairman & CEO

Assessment: This is the highest-confidence line item in the entire investment case, and it is under-appreciated precisely because it is boring. Roughly half of the multi-year margin expansion is mechanical: it does not require volume, pricing power, or an end-market cycle. It requires a cost-removal program to finish, and that program is currently ahead of schedule with the finish line visible in early 2027. Investors accustomed to discounting industrial margin targets because they depend on volume should discount this one less.

3. Quantinuum: A $6.6B Gain, a 47% Stake, and $7.3B Now Sitting on the Balance Sheet

Quantinuum completed its initial public offering in June and deconsolidated from Honeywell, producing a $6,629M gain that carried GAAP EPS from continuing operations to $17.83 and is stripped entirely from the $4.52 adjusted figure. Honeywell retains a 47% ownership stake, now carried under the equity method: equity-method investments on the balance sheet rose to $7,459M at June 30 from $206M at December 31. The stake generated a $265M equity loss in the quarter, also excluded from adjusted results. Management deferred any statement of intent.

"On Quantinuum, we expect to provide more color on our plans of our 47% ownership stake by early next year." — Vimal Kapur, Chairman & CEO

Assessment: This is the most mispriced item in the story and the analytical core of our upgrade. Roughly $7.3B of carrying value, about $23 per diluted share against a $247 stock, is an asset that contributes zero to the adjusted earnings the market applies a multiple to, and actively subtracts from GAAP earnings. Every screen showing HON at 30x is dividing a market capitalization that includes this stake by an earnings number that excludes it. Netting it out puts the operating business near 27x the 2026 guide. The stake is a mark rather than cash, it is in a volatile and newly public security, and monetization would carry tax, so it deserves a haircut rather than face value. But it deserves considerably more than the zero the headline multiple assigns it, and "more color on our plans" by early next year is a stated catalyst for closing that gap.

4. The Divestitures Closed Two Months Early, Costing Revenue and Adding Margin

Productivity Solutions and Services and Warehouse and Workflow Solutions will both close by early August, roughly two months ahead of the original planning assumption. The acceleration removes approximately $400M from the 2026 revenue expectation, which is why the full-year sales guide came down to $19.8–20.0B from $19.9–20.2B in the same breath that the organic growth guide went up to 3–4% from 2–3%.

"This is approximately 2 months ahead of our initial planning assumption, which has reduced our 2026 revenue expectation by approximately $400 million." — Vimal Kapur, Chairman & CEO

Assessment: A reader scanning only the sales line would record a guidance cut. The opposite happened. Losing $400M of low-margin revenue two months early is accretive to segment margin, contributed to the 25bp midpoint raise in the margin guide, and the lost income was more than offset in the EPS raise. This is the clearest example in the print of why the reported top line is close to uninterpretable this year and why organic growth and segment margin are the only two revenue-side metrics worth tracking.

5. Johnson Matthey Catalyst Technologies: Closed July 17, at a Renegotiated Price

The Johnson Matthey Catalyst Technologies acquisition closed on July 17 after a renegotiation that lowered the price, landing at roughly 13x EBITDA on 2027 earnings, the first year of full ownership. Management was explicit that the multiple is justified on cost synergies alone and that the commercial rationale, which is the actual reason for the deal, is excluded from the underwriting. The business complements Honeywell UOP in hydrogen, methanol and ammonia, adjacencies where Honeywell had no capability, rather than overlapping in refining and petrochemicals where it did.

"we remain excited about how we got the deal done at about 13x EBITDA with cost synergies, no sales synergies." — Vimal Kapur, Chairman & CEO

Assessment: Negotiating a signed price downward is rare and is a credit to capital-allocation discipline, particularly against a seller with a public timetable. Underwriting at 13x on cost synergies alone with the revenue case held entirely outside the model is the conservative construction, and it means the acquisition can only surprise upward in the numbers. The strategic logic is sound: buying complementary technology in adjacent process chemistries and then monetizing the acquired installed base through Honeywell's own services and software is precisely the "grow and monetize the installed base" strategy the June Investor Day was built around, executed rather than described.

6. The Middle East Flipped From Revenue Headwind to Order Tailwind

The conflict that cost roughly 0.5% of revenue in Q1 and was assumed to cost about 1% in Q2 has stabilized. Collection issues concentrated in March and April and have begun to normalize; management characterized the residual as modest and immaterial but took a prudent posture on the exposed customer set. Middle East orders grew more than 50% in the quarter on large Process Technology awards, and management expects Middle East revenue up high single digits for the full year with orders up roughly 40%. Critically, the guide no longer assumes recovery.

"Regarding the conflict, we are assuming the situation remains as it is today with no improvement from the current situation, but also no significant escalation in the war or further disruption to the supply chain." — Vimal Kapur, Chairman & CEO

Assessment: Last quarter we identified "the Middle East clears by Q3" as the guide's most exposed premise. Management has removed that premise. The current guide assumes the status quo persists, which converts a forecasting risk into an upside option, and the fact that they raised guidance while tightening that assumption is more meaningful than the raise itself. Honeywell also appears to be genuinely differentiated in the region on account of a heavily localized workforce that did not evacuate, plus a portfolio weighted to exactly what the region is buying. A material escalation remains a live risk, but the asymmetry now runs the right way.

7. The Three-Year Algorithm, and Why It Is Already Being Beaten

The June 11 Investor Day set the framework this company will be judged against: approximately $12 of adjusted EPS by 2029 representing more than 10% annual growth, a 24% segment-margin target, and free cash flow conversion above 90% with line of sight to 95% in the second half of this year. Six weeks later the first quarter against that framework came in above management's own early-June expectation, and the CFO stated that 2027 is tracking better than what was presented.

"Collectively, this will drive approximately $12 of adjusted EPS, representing more than 10% growth annually." — Vimal Kapur, Chairman & CEO

Assessment: A $8.20 midpoint in 2026 compounding to approximately $12 in 2029 is a low-teens earnings CAGR, not the "more than 10%" management describes, so the framework itself is conservatively worded. Combining that with a beat in the first quarter against it, a raise, an explicit statement of further room, and a stated improvement in the 2027 outlook produces an unusual configuration: a newly independent company that has already established a pattern of setting a bar and clearing it. Credibility compounds faster than earnings in the first year of a standalone story, and this is what building it looks like.

8. Cash Conversion Finally Turned

Free cash flow reached $456M against $114M a year ago, driven by higher income plus working-capital improvement, which more than offset the ongoing Middle East collection headwind. Operating cash flow from continuing operations tripled to $563M. Management maintained roughly $2B of free cash flow for the year with the majority in the second half and a conversion rate near 95%. Capital deployment in the quarter was about $1B, roughly $800M of dividends and $200M of capital expenditure, with more than $2.8B deployed year to date across buybacks, dividends and investment.

Assessment: Cash conversion has been the softest part of the Honeywell story throughout our coverage, and the 90%-plus target has been a promise across four consecutive recaps. This quarter is the first hard evidence, and the required second-half conversion of roughly 95% is now the specific number to hold management to. Note that the full-year target is unchanged despite the earnings raise, which means either conservatism or a working-capital build to fund the second-half revenue ramp. We read it as the former, but a Q3 conversion below 90% would make it the latter.

9. Price Is Covering Inflation and Nothing More

Pricing ran 3.5–3.7% in the quarter and is expected near 4% in the second half, which management expects to match inflation. Inflation is described as stubborn and broad, specifically in electronics, memory, copper and labor.

"essentially, we're able to cover inflation with price, but inflation is stubborn. We see a lot of inflation in electronics, memory, obviously, copper, and we also see inflation in labor." — Mike Stepniak, SVP & CFO

Assessment: This is a quietly important disclosure that cuts both ways and, on balance, favors the bulls. It means none of the 100bp of margin expansion was borrowed from a favorable price/cost spread that could reverse, which makes the expansion more durable than a typical industrial print. It also means there is no pricing cushion if inflation accelerates, and memory and electronics inflation is a live and worsening input for a sensing-heavy portfolio. We would rather own margin built on productivity with no price cushion than the reverse, but this is the input to watch if the data-center-driven component cycle tightens further.

10. Software ARR and the AI Question

Recurring software revenue on the Forge platform is expected to grow about 15% in 2026, moving from roughly $900M toward a little over $1B of annual recurring revenue. Asked directly whether physical AI is driving incremental hardware demand, management declined to claim a separate AI demand signal, framing Forge ARR growth as the only clean measurable proxy because AI capability is embedded across the product set rather than sold separately.

"To me, AI is an integral part of our offering set… the best way to measure our progress to see our ARR growth. I cannot give you any other indicator because they are all wrapped up into other products." — Vimal Kapur, Chairman & CEO

Assessment: Declining to manufacture an AI narrative when the question was handed over unprompted is a credibility marker in the current environment, and the ARR disclosure is a falsifiable metric rather than a story. The offset is that roughly $1B of ARR against a $20B revenue base means the recurring-revenue pivot that underpins the multi-year margin mix improvement is still early, and 15% growth on that base moves the consolidated needle slowly. This is a 2028–2029 thesis component, not a 2026 one.

11. Capital Allocation: Debt First, M&A From 2027

Management was direct that 2026 is a deleveraging year and that meaningful M&A should be viewed through a 2027-and-beyond lens, with a target deal size of $1–5B of enterprise value. The stated priority order for acquisitions is strengthening the Industrial Automation sensing and measurement portfolio first, then adding to the eight designated high-growth verticals, then technology tuck-ins. The $12 EPS target assumes no acquisitions at all.

"all our earnings forecast of $12 by 2029 is based upon organic growth. There's not even single M&A assumed in that because we all know that's unpredictable, and we'll see what comes on our way." — Vimal Kapur, Chairman & CEO

Assessment: A wholly organic $12 target is a materially better disclosure than one that quietly assumes capital deployment, because it means the balance sheet capacity and the eventual Quantinuum proceeds are incremental to the plan rather than embedded in it. The sequencing is also correct: current maturities of long-term debt rose to $5,282M from $1,546M at year-end following the separation financing, so retiring debt before shopping is the right order of operations.

Guidance & Outlook

The comparison below is against the June 8, 2026 standalone guidance, not against the Q1 guide. The Q1 guide covered pre-spin Honeywell International and is not comparable to anything in this table.

What the guide actually asks for. The full-year organic range of 3–4% against a first half that delivered roughly 4% in Q2 requires 4–6% in the second half, which is a real acceleration but a smaller one than the year began needing. The heavy lifting sits in two places. Process Automation & Technology must travel from minus 1% to high single digits, funded by backlog conversion and catalyst shipments running 25–30% above the first half. Industrial Automation must sustain low-single-digit growth on a smaller post-divestiture base. Both segments had their full-year organic outlook raised from roughly flat to up low single digits, which is where the top-line raise originates; Building Automation was left at mid-single-digit-plus despite seven consecutive high-single-digit quarters.

The margin ramp is steeper than the revenue ramp. Exiting the year above 22% segment margin against a 20.1–20.5% full-year guide implies roughly two points of sequential expansion from the third quarter to the fourth. Management attributes it broadly across all three segments, with the largest single step in Industrial Automation, where the CFO committed to a 22% fourth-quarter margin against 17.2% today. Roughly half of the total expansion is structural (portfolio actions and stranded costs) and half operational, with management describing the operational component as currently running at 100–120bp.

Guidance style: a raise with room left in it. Two data points suggest the raised numbers are still conservative. The Middle East assumption was tightened to no improvement while the guide went up, and Building Automation's outlook was not raised despite orders growing 13%. Management said so directly.

"We raised the guidance, as you saw, but I also think there is more room as we're going to go into the third quarter and fourth quarter to beat even the raised guidance." — Mike Stepniak, SVP & CFO

Analyst Q&A Highlights

Middle East Collections and the Risk of Force Majeure

The opening line of questioning went straight to the region that has been the principal drag on the last two quarters, probing whether the acknowledged collection issues carried contractual risk behind them. Management separated the two cleanly: revenue was lost in the first and second quarters as guided, collections were a March and April problem that has begun to normalize, and there is no exposure to disputes of consequence. The quantified forward view was more constructive than the framing of the question implied.

Q: "Since it is so topical, I'd like to circle back on the Middle East impacts. I mean you still had double-digit orders. So you still have got momentum there. Just I'm interested about the idea that you've got some collection issues. Is there any risk of like force majeure here and any kind of disruptions like that?"
— Deane Dray, RBC Capital Markets

A: "majority of our collection issues happened in March and April in Middle East. That started to normalize. We still expect the revenue in Middle East to be about high single digits this year and orders should be about 40%. So we look really forward to seeing Middle East perform in the second half and next year."
— Mike Stepniak, SVP & CFO

Assessment: A full-year expectation of high-single-digit revenue growth and roughly 40% order growth in the region that was a quantified headwind one quarter ago is a larger swing than the raise to the consolidated guide reflects. The answer also implicitly confirms the collection drag is behind rather than ahead, which is corroborated independently by the free-cash-flow line. The remaining exposure is a step-function escalation risk, which no guide can carry.

What Changed in the Six Weeks Between Setting Guidance and Raising It

Because the standalone guidance was only established on June 8, a recurring line of questioning pressed on what could possibly have improved fast enough to justify a raise on July 23. The answer pointed to order composition rather than any single event, and then went further than the question asked by volunteering that the raised numbers are themselves beatable.

Q: "it's obviously good news to see the guidance increasing. You did indicate that in June that there was scope for upside. But I'm curious if there's anything you saw in June, July to give you more confidence? Just any color in terms of how we exited 2Q entered 3Q on your markets?"
— Nigel Coe, Wolfe Research

A: "what we saw in the second quarter, we feel extremely, I would say, confident in the second half… as you saw, orders across the board were strong. Every business printed double-digit short-cycle orders in the second quarter, which gives us a lot of confidence in the third quarter and the fourth quarter… I also think there is more room as we're going to go into the third quarter and fourth quarter to beat even the raised guidance."
— Mike Stepniak, SVP & CFO

Assessment: Volunteering that a just-raised guide has further room is a strong signal and an unusual one, particularly from a CFO in the first quarter of a standalone company where the incentive runs entirely the other way. Sandbagging the first year is the conventional playbook; saying out loud that you have sandbagged it is not. The specific justification, double-digit short-cycle orders in every segment, is the right one, because short-cycle is what converts inside the guided period.

The Stranded-Cost Trajectory Against the Investor Day Plan

A line of questioning sought a finer point on the claim that stranded-cost removal was running ahead of plan, specifically whether the timeline had changed versus what was presented in June. The response was quantified against the June baseline rather than described qualitatively.

Q: "on stranded costs, you guys referred to making more progress than expected. Can you just put a finer point on that with respect to any changes in the stranded cost reduction time line versus what we got at the Investor Day or in the periods before?"
— Nicole DeBlase, Deutsche Bank

A: "at the Investor Day, I think we said something around $85 million of stranded costs at year-end. This is about $20 million better right now. So we should enter 2027 with about $60 million, $65 million of stranded costs that we'll proceed to eliminate early next year."
— Mike Stepniak, SVP & CFO

Assessment: Beating a six-week-old cost target by roughly a quarter of its remaining balance, with a specific residual named and a date attached, is the kind of answer that converts a margin target from an aspiration into a schedule. This is also the answer that independently corroborates the roughly $31M narrowing in the implied corporate drag visible in the segment tables, which means the disclosure and the accounts agree. That agreement is worth more than either alone.

Operational KPIs Behind the Industrial Automation Turnaround

A questioner declined to accept the margin improvement at face value and asked for the underlying operating metrics driving it, specifically on-time delivery. Management supplied a concrete trajectory with a starting point, a current position and a target, which is the first time this turnaround has been made measurable from outside.

Q: "maybe can you talk about industrial automation, just maybe you can give some KPIs on improving performance, I don't know, sort of on-time delivery. Anything you want to share how you're moving along in improving execution in this segment driving this improvement?"
— Andrew Obin, Bank of America

A: "the KPIs we are looking at it is, first, of course, how our delivery performance is improving. It's a very channel-driven business. So the sensitivity to the delivery performance is high. We're working towards high 80s percent performance as we progress through the course of the year… we were in mid-40s, and we are trending from 40% towards 80% as we speak at this point of time."
— Vimal Kapur, Chairman & CEO

Assessment: On-time delivery moving from the mid-40s toward 80% inside two quarters explains the 20%-plus order growth in Sensing and Industrial Measurement better than any commentary about new products does, because in a channel-driven business delivery performance is the product. It also makes the turnaround falsifiable: if delivery stalls in the 70s, the fourth-quarter 22% margin commitment is the first thing that breaks. This was the most useful exchange on the call for anyone underwriting the segment.

Revenue Synergies Deliberately Excluded From the Johnson Matthey Underwriting

A line of questioning probed the gap between the stated acquisition multiple and the strategic case, asking how quickly the excluded commercial synergies might be captured. The answer confirmed the multiple rests on cost synergies alone and laid out three separate revenue paths held outside the model.

Q: "as you've noted, you don't want to include revenue synergies in your outlook, but maybe just a little color on where you get after those, how quickly you might be able to capture some of those?"
— Jeffrey Sprague, Vertical Research Partners

A: "even though right now, the headline number is 13x EBITDA based on 2027 earnings because that's the first year we'll fully own the business, but that's purely cost synergy based. We haven't acquired the business for cost synergies. We have acquired it to add value through sales synergies."
— Vimal Kapur, Chairman & CEO

Assessment: An acquisition underwritten so that the strategic rationale is entirely upside to the returns math is the structure a shareholder should want, and it is the opposite of the pattern that gets industrial acquirers into trouble. The three named paths, combining complementary chemistries into single propositions, attaching Honeywell services and software to Johnson Matthey's installed base, and using that installed base as a door-opener for process automation, are specific enough to be tracked. The risk is the familiar one: revenue synergies excluded from the model are also excluded from the accountability.

How Much Conservatism Is in the Second-Half Guide, and What It Implies for 2027

A recurring theme in the back half of the call was whether the raised second-half range still understates the order book, and whether long-cycle bookings are already underwriting the following year. The response conceded conservatism and then made an unprompted forward statement about 2027 relative to the framework presented six weeks earlier.

Q: "a broader question on the guidance, the 4% to 6% baked into the second half of the year. Obviously, the trailing 12-month orders up double digits is very supportive of that guide. It does sound like there's probably maybe some conservatism into the second half as well. But I guess the question I have is how much of what you're seeing from an order perspective today is maybe even like longer cycle and is already starting to help support a pretty good outlook for 2027 as well?"
— Joseph Ritchie, Goldman Sachs

A: "I would say it's both. And I think versus what we guided at the Investor Day for 2027 and looking where we're entering the second half and all things are progressing given the strength across the board in the short cycle and then the continued orders on the long cycle, you're right, our 2027 incrementally is looking stronger versus when we talked even last month."
— Vimal Kapur, Chairman & CEO

Assessment: This is the single most valuable sentence on the call for anyone valuing the stock off forward earnings, because the multiple debate is a 2027 debate rather than a 2026 one. A management team saying its second forward year is tracking above a framework it published six weeks prior, in the first quarter it has ever reported as an independent company, is offering the market a reason to underwrite the out-years rather than wait for them. It is also, of course, unverifiable until the January guide.

Price Versus Cost, and What the Margin Expansion Is Actually Made Of

A questioner pressed on the price/cost spread given the better-than-expected margin, seeking to establish whether pricing was doing the work. Management's answer removed pricing from the explanation entirely and named the actual drivers.

Q: "can you comment on price versus cost? As you know, commodity inflation is obviously all over the place, but your margin that you said is trending a little better than expectations. So maybe just talk about what you're seeing and what, if any updated thoughts you have for price versus cost in the second half of '26."
— Andrew Kaplowitz, Citigroup

A: "Price was about 3.5%, 3.7% for the second quarter. I think looking at the second half, it will be around 4%, and that's where we see inflation to be… I would say a lot of the margin expansion you see here from us is not really driven by price cost, but it's really by our productivity, stranded cost takeout and the teams just being able to get a much better leverage on cost and NPI introductions."
— Mike Stepniak, SVP & CFO

Assessment: Management could have claimed pricing power and was not asked to disclaim it. Attributing the expansion to productivity and cost removal instead, while conceding price merely covers inflation, is the less flattering and more useful answer, and it substantially raises our confidence in the durability of the 100bp. A margin built on price is hostage to the next competitor who discounts; a margin built on a cost structure being permanently reset is not.

What They're NOT Saying

1. There is no stated plan for the 47% Quantinuum stake, and it is roughly 9% of the market capitalization. "More color on our plans… by early next year" defers the single largest discrete value question in the story by two quarters. Whether the stake is sold, distributed, held, or used to fund the 2027 M&A pipeline changes the per-share math materially, and investors are being asked to carry it as an unvalued balance-sheet item in the meantime.
2. Process Automation & Technology revenue growth was never bridged quarter by quarter. The segment must travel from minus 1% to high single digits, and the explanation given was directional (backlog conversion plus 25–30% higher second-half catalyst volumes) rather than a Q3-to-Q4 build. Given that the same segment's margin swung 180bp on catalyst mix alone, the shape of that ramp matters as much as its destination, and it was not provided.
3. The 2026 revenue base has now been restated so many times that year-over-year comparison is effectively unavailable. Aerospace spun on June 29 and moves to discontinued operations in Q3. Two divestitures close in early August, removing about $400M. Johnson Matthey closed July 17, adding revenue. Quantinuum deconsolidated. Pension income and Quantinuum were stripped from adjusted results across all prior periods, and a 1-for-2 reverse split reset every per-share figure. No investor can construct a clean sequential model of this company for 2026, and management did not offer a bridge that would let them.
4. Building Automation's guide was not raised despite orders growing 13% and seven consecutive high-single-digit quarters. Management conceded on the call there is "no real logic" for the growth rate to fade, then left the segment guided to mid-single-digit-plus. That is either prudence in a first standalone year or an unstated expectation that the vertical mix normalizes. It was not explained.
5. Free cash flow guidance was maintained at roughly $2B while earnings guidance went up. An EPS raise that does not pull cash guidance with it implies either conservatism or a working-capital build to fund the second-half revenue ramp. Neither was addressed, and the required second-half conversion of about 95% is a demanding number against a company that converted well below that in the first half.
6. The GAAP result was not discussed. Operating income fell 6% at the consolidated level and operating margin contracted 190bp, while $820M of divestiture-related costs and a $6,629M deconsolidation gain ran through the quarter. The prepared remarks addressed adjusted figures almost exclusively. The adjustments here are defensible and clearly disclosed, but a quarter in which GAAP EPS quadruples on a non-cash gain deserves more airtime than it received.
7. Nobody asked, and management did not volunteer, what the Aerospace trademark agreement is worth. It is named as one of three contributors to the 200bp-plus of structural margin expansion, alongside stranded costs and Industrial Automation portfolio actions, yet it has never been sized. Of the three legs of the structural margin story, two are now quantified and this one is not.

Market Reaction

• Pre-print setup: HON closed at $232.99 on July 22, at the top of its post-separation trading range. Across the seventeen sessions between the June 29 spin and the print, the stock traded between $220.36 and $232.99, drifting sideways as the market waited for the first standalone datapoint.
• Reaction session (July 23, before-open reporter): Opened at $238.00, a 2.2% gap, traded as high as $250.27, and closed at $246.27, up 5.7% or $13.28, on 6.3M shares against a 5.2M thirty-day average (1.2x). The close was a new post-separation high.
• Market context: The S&P 500 fell 1.2% on the session, so the move was entirely company-specific and worth roughly 7 points of relative performance in a day.
• Follow-through: The move has held and extended rather than faded, with closes of $243.15, $245.75 and $247.05 in the three sessions since.

The reaction reads as a straightforward repricing of an uncertainty premium. A newly independent company with a six-week-old guidance framework, three segments the market had never seen reported separately, and a revenue base scrambled by a spin, two divestitures, an acquisition and a deconsolidation was always going to trade with a discount for unknowability. Beating on both lines and raising the growth, margin and EPS legs of that framework in the first print retires a meaningful part of that discount at once.

The composition of the move supports that reading over a simple beat reaction. Volume at only 1.2 times the thirty-day average is modest for a 5.7% move, which suggests repricing by existing holders rather than a wave of new capital, and the stock opened up just 2.2% before working higher through the session as the call progressed, closing at +5.7% having traded as high as +7.4%. A measured gap that more than doubles by the close, rather than a spike that gives most of itself back, is the signature of a market being convinced by the call rather than by the release. The order line and the CFO's statement that the raised guide still has room are the two things on the call most likely to have done the convincing.

What the move does not reflect, in our view, is the Quantinuum stake. A 5.7% session move on a beat-and-raise is an ordinary response to an ordinary beat-and-raise. Repricing a $7.3B balance-sheet asset that the reported earnings exclude would look considerably different, and management's deferral of any plan until early next year means there was no reason for it to happen on this date.

Street Perspective

Debate: Is 30x the Right Price for a Pure-Play Automation Compounder?

Bull view: The optimistic camp argues the denominator is wrong. A 2026 base still carrying stranded costs is the trough of the earnings algorithm, not a fair basis for a multiple, and the relevant comparison is roughly 27x the following year against a low-teens earnings compounder with structural margin expansion, better than 90% cash conversion and secular exposure to data centers, LNG and grid infrastructure. Premium automation assets have historically cleared the high twenties, and this one is guiding to 24% segment margins.

Bear view: The skeptics counter that 30x on the current year is 30x regardless of the framing, that the growth underneath it is narrower than the multiple implies, since the largest segment shrank organically this quarter and the core of the third grew 2%, and that essentially all of the visible growth is concentrated in one segment and in orders that have not yet become revenue. Paying a premium multiple for a company whose acceleration is still entirely prospective is the classic first-year-of-a-spin error.

Our take: Both sides are arguing about a numerator that is misconstructed. Roughly $23 per share of the price is a retained Quantinuum stake that contributes nothing to the earnings being divided into it, so the operating business is nearer 27x this year and 24x our 2027 estimate. That is a fair-to-attractive price for this asset rather than an expensive one. The bears are right that the growth is narrow today; they are underweighting that the margin half of the algorithm is structural and already running ahead of schedule.

Debate: Do the Orders Convert, or Is the Second Half Still a Show-Me?

Bull view: The constructive case holds that 16% organic order growth with double-digit short-cycle in every segment, book-to-bill at 1.1 overall and above 1.2 in Process Automation, and backlog up 9% is about as much forward evidence as a company can provide one quarter ahead. Short-cycle orders convert inside two quarters by definition, so the second-half guide is underwritten by bookings already in hand rather than by a pipeline.

Bear view: The skeptical camp notes that this same segment was promised as a second-half inflection at the Q1 call too, and delivered minus 1% in the interim. The full-year guide asks Process Automation to swing roughly nine points in two quarters on catalyst shipments that management itself describes as difficult to forecast within a quarter, in a business where a single large shipment moved the prior-year comparison enough to explain the entire margin contraction.

Our take: The bulls have the stronger argument, but by less than the order growth suggests. A book-to-bill above 1.2 is a materially harder fact than the backlog assurances offered in April, and the short-cycle composition is the specific detail that makes it credible for this year rather than next. The residual risk is timing inside the half rather than the level across it. We would expect a Q3 that looks better on orders and margin than on Process Automation revenue, and would not treat that as a thesis break.

Debate: How Should the Quantinuum Stake Be Valued?

Bull view: One camp argues the stake should be marked close to its $7.3B carrying value and treated as near-term realizable, given the June listing established a public market price, the company has committed to articulating a plan by early next year, and the proceeds would land on a balance sheet already prioritizing deleveraging with a 2027 acquisition pipeline waiting behind it.

Bear view: The other camp argues a 47% stake in a newly public, pre-profit quantum-computing company deserves a steep haircut for volatility, lock-up constraints, the tax leakage a sale would trigger, and the simple fact that a minority position in a business Honeywell no longer controls is worth less than its mark. It is also currently a drag, having cost $265M in equity losses in a single quarter.

Our take: The truth is closer to the bulls than the market's current treatment, which effectively assigns the stake zero. We carry it at a discount to the carrying value in our base case to reflect tax and volatility, and note that the direction of any surprise is asymmetric: a stated monetization plan by early next year forces the market to assign it some value, and almost any positive number is an improvement on how it is priced today. The equity losses are irrelevant to the valuation question, since they are excluded from the adjusted earnings the multiple is applied to.

Model & Valuation Framework

Valuation framework. At the July 28 close of $247.05 and roughly 319M diluted shares, Honeywell Technologies carries a market capitalization near $78.8B. Against the $8.20 guide midpoint that is 30.1x, which is where the "expensive industrial" reflex comes from. The reflex is wrong in one specific and quantifiable way. The balance sheet at June 30 carried $7,459M of equity-method investments against $206M at December 31, essentially all of which is the retained 47% Quantinuum stake, and that asset generates none of the $8.20. Removing roughly $23 per share of non-earning value from the numerator puts the operating business at about 27.4x the 2026 guide.

The 2026 base is also the wrong denominator for a company mid-way through resetting its cost structure. Management expects to exit this year above 22% segment margin against a 20.1–20.5% full-year guide, and to carry only $60–65M of stranded cost into 2027. Applying the company's own low-teens algorithm to the $8.20 midpoint gives roughly $9.30 for 2027, against which the operating business trades near 24x. For a business guiding to 24% segment margins, better than 90% cash conversion, and low-teens earnings growth with zero acquisitions assumed, 24x is a reasonable price rather than a demanding one.

Our $280 base case applies 28x to that $9.30 and adds $20 for the stake, a discount to the $23 carrying value for tax and volatility, implying roughly 13% upside. The $326 bull case assumes the CFO's stated room to beat is real (2027 nearer $9.70), the multiple holds at 31x on a company that has by then beaten its framework four times, and the Quantinuum plan crystallizes closer to full value. The $226 bear case is the Process Automation ramp slipping into 2027, 2027 landing at $8.80, a de-rating to 24x, and the stake discounted hard, for roughly 9% downside. The skew is approximately 1.6:1 on base-versus-bear and considerably wider to the bull case, which is the asymmetry a Hold was waiting for.

Thesis Scorecard Post-Earnings

Grading the standing thesis carried since our July 2025 initiation. Two pillars retire this quarter, not because they failed but because the corporate action they described has completed: the sum-of-the-parts unlock is done, and the Aerospace franchise is now a separate security. One bull pillar and one bear point are added to reflect that the entity being rated changed on June 29.

Overall: Thesis materially strengthened. Of the three bear points carried into this quarter, two were challenged and pushed back to contained, and the third softened once the Quantinuum stake is netted out of the multiple. Both bull pillars that survive the separation were confirmed, one of them emphatically on the exact metric that drove our April downgrade. The new risk we add is narrower and more specific than the ones it replaces: not whether this business works, but whether one segment converts its backlog on the guided schedule.

Action: Upgrade to Outperform. Add on any Process Automation-driven weakness in the third quarter, which we would treat as timing rather than thesis. We would return to Hold if the segment misses without an order-book explanation, if price/cost turns negative, or if the multiple runs beyond roughly 30x our 2027 estimate net of the Quantinuum stake without a corresponding raise. We would move to Underperform only if the second-half inflection fails outright and the 2029 framework is walked back.

Bottom Line: The Downgrade Was Early, and This Quarter Says So

Three months ago we downgraded Honeywell to Hold at $214, arguing the valuation discount had closed, that two fresh headwinds had emerged, that orders had decelerated to 7%, and that the sum-of-the-parts had become imminent-and-priced rather than discounted. We wrote that we were banking the win from the October upgrade and would re-engage on either a pullback or June disclosures revealing more value than the market had priced. The stock did not pull back. It went up, and holders also received Honeywell Aerospace shares on top. That call was early, and the honest accounting is that the discipline was right in principle and wrong in timing.

What has changed is not the price, which is higher, but the evidence. The order deceleration that anchored the downgrade reversed to 16% organic growth with double-digit short-cycle demand in every segment. The Aerospace supply-chain disruption resolved on management's stated timeline, which retroactively validates how this team characterizes its own problems. The Middle East went from a quantified revenue headwind to more than 50% order growth, and the guide was tightened to assume no recovery at the same time the numbers went up. Free cash flow, the softest line in this story across four consecutive recaps, quadrupled. And the separation itself, which we treated as an execution risk, completed on its date with stranded-cost removal running roughly $20M ahead of a plan set only six weeks earlier.

The second re-engagement condition has been met, though not in the form we anticipated. We expected the June Investor Days to reveal value through the standalone financial frameworks. They did set a credible algorithm, roughly $12 of adjusted EPS by 2029 with 24% segment margins and better than 90% cash conversion, and this quarter is already running ahead of it. But the larger unpriced item turned out to be on the balance sheet rather than in the model. Equity-method investments jumped to $7,459M from $206M when Quantinuum deconsolidated, which means roughly $23 of the $247 share price is a 47% stake in a newly public company that contributes nothing to the adjusted earnings every screen divides into that price. The stock is not 30x. Net of the stake, the operating business is nearer 27x this year and roughly 24x our 2027 estimate, with a stated catalyst for repricing the stake by early next year.

What we own here is a pure-play automation company with a compounding order book, a margin expansion program that is roughly half mechanical and running ahead of schedule, a cost structure being permanently reset rather than cyclically flexed, and a management team that raised its own six-week-old guidance and then said out loud that there is more room in it. The price is full on the screen and reasonable in the accounts. The single thing that has to go right is Process Automation converting a book-to-bill above 1.2 into revenue in the third quarter. That is a narrower risk than the ones we were underwriting in April, and it is compensated. Upgrading to Outperform from Hold.